Vasomotor 증상 시장 규모 및 점유율 분석 - 성장 추세 및 예측 (2024 - 2031)
Vasomotor 증상 시장은 치료 (Hormone Therapy, Non-hormonal Medications, Lifestyle Modifications, Behavioral Therapies)에 의해 구분됩니다, 관리 (오랄, 육아, 기타), End-use (Hospitals, Homecare, Specialty Clinics), By Distribution Channel (Retail Pharmacy, Online Pharmacy, Others), Geography (북미, 라틴 아메리카, 아시아 태평양, 유럽, 중동 및 아프리카. 보고서는 상기 언급 된 값 (USD 억)을 제공합니다.
Competitive overview of Vasomotor 증상 시장
Vasomotor Symptoms 시장에서 운영하는 주요 선수는 Therapeutics MD, Mithra Pharmaceuticals, KaNDy Pharmaceuticals, Fervent Pharmaceuticals, Astellas Pharma, Sojournix, Mitsubishi Tanabe Pharma, Teva Pharmaceuticals Ltd, Pfizer Inc., Hikma Pharmaceutical Plc, Dr. Reddy's Laboratories Ltd, Abbvie, Inc, Endo Pharmaceuticals Plc, Novartis AG 및 WOCKHARDT를 포함합니다.
Vasomotor 증상 시장 Leaders
- 치료 MD
- Mithra 제약
- KaNDy 제약
- Fervent 제약
- Astellas 약
*Disclaimer: Major players are listed in no particular order.
Vasomotor 증상 시장 - Competitive Rivalry, 2023
Vasomotor 증상 시장
Market Consolidated
(Dominated by major players)
(Dominated by major players)
Market Fragmented
(Highly competitive with lots of players.)
(Highly competitive with lots of players.)
*Source: Coherent Market Insights